Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and
is set out in the Schedule hereto:
Schedule
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25Ág/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Chiron S.r.l, Bellaria, Rosia, Sovicille, Italy
Note: This consent is given subject to the following conditions:
? This vaccine is for use in individuals aged six weeks or older.
Note: This medicine has provisional consent that expires on 8 July 2006.
Dated this 1st day of February 2005.
KAREN POUTASI, Director-General of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).